$7.31
0.162.24%
At close: -
$7.25
-0.06-0.82%
After Hours: 6:36 PM EDT
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $-1.56 | $-1.36 | -14.7 % |
Q3 | 2024-10-29 | $-1.53 | $-1.53 | 0.00 % |
Q2 | 2024-07-31 | $-1.70 | $-1.66 | -2.41 % |
Q1 | 2024-04-25 | $-1.80 | $-1.65 | -9.09 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $12.82M | $14.37M | -10.8 % |
Q3 | 2024-10-29 | $11.87M | $10.80M | 9.92 % |
Q2 | 2024-07-31 | $8.65M | $8.85M | -2.19 % |
Q1 | 2024-04-25 | $7.90M | $5.66M | 39.6 % |
Sage Therapeutics (SAGE) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
The Actual EPS was $-1.56, which missed the estimate of $-1.36.
The Actual Revenue was $12.8M, which missed the estimate of $14.4M.
Browse earnings estimates, EPS, and revenue on all stocks.